BioNTech Founders to Transition to New Company by Year-End

BioNTech announced that its founders, Ugur Sahin and Özlem Türeci, will transition to a new company by the end of the year. Bloomberg posted on X, highlighting the significant move for the couple who played a pivotal role in developing the COVID-19 vaccine. The transition marks a new chapter for Sahin and Türeci, who have been instrumental in BioNTech's success. The company did not provide further details about the new venture or its focus. BioNTech, known for its groundbreaking work in mRNA technology, continues to explore new opportunities in the biotech sector.